Intestinal glucose and amino acid absorption in healthy volunteers and noninsulin-dependent diabetic subjects. 1989

M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
Department of Endocrinology, North Staffordshire Royal Infirmary, Stoke on Trent, UK.

Reducing the rate of glucose absorption is a useful approach to the treatment of noninsulin-dependent diabetes mellitus (NIDDM). Intestinal absorption of glucose and amino acids is known to be increased in diabetes in laboratory animals but has not been systematically studied in human NIDDM subjects. In this study the intestinal absorption of glucose and glycine was measured during steady-state perfusion of the jejunum in 10 NIDDM subjects and in 11 healthy volunteers. Absorption rates were linearly related to solute load for both glucose and glycine. Over the range of solute concentrations, absorption rates of glucose (F = 4.38, p less than 0.05) and glycine (F = 7.07, p less than 0.02) were slightly reduced in diabetic subjects. The reduction in absorption rates may be accounted for by differences in age and diet between the groups. It is concluded that glucose and amino acid absorption is not increased in human NIDDM.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005998 Glycine A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. Aminoacetic Acid,Glycine, Monopotassium Salt,Glycine Carbonate (1:1), Monosodium Salt,Glycine Carbonate (2:1), Monolithium Salt,Glycine Carbonate (2:1), Monopotassium Salt,Glycine Carbonate (2:1), Monosodium Salt,Glycine Hydrochloride,Glycine Hydrochloride (2:1),Glycine Phosphate,Glycine Phosphate (1:1),Glycine Sulfate (3:1),Glycine, Calcium Salt,Glycine, Calcium Salt (2:1),Glycine, Cobalt Salt,Glycine, Copper Salt,Glycine, Monoammonium Salt,Glycine, Monosodium Salt,Glycine, Sodium Hydrogen Carbonate,Acid, Aminoacetic,Calcium Salt Glycine,Cobalt Salt Glycine,Copper Salt Glycine,Hydrochloride, Glycine,Monoammonium Salt Glycine,Monopotassium Salt Glycine,Monosodium Salt Glycine,Phosphate, Glycine,Salt Glycine, Monoammonium,Salt Glycine, Monopotassium,Salt Glycine, Monosodium

Related Publications

M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
December 1988, Alcoholism, clinical and experimental research,
M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
January 1975, Zeitschrift fur Kinderheilkunde,
M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
December 1992, American journal of ophthalmology,
M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
January 1993, European journal of clinical pharmacology,
M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
December 1982, The Journal of clinical endocrinology and metabolism,
M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
June 1985, The Journal of clinical endocrinology and metabolism,
M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
October 1984, The Journal of clinical investigation,
M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
December 1991, The Journal of clinical endocrinology and metabolism,
M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
January 1984, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
M C Gulliford, and E J Bicknell, and G G Pover, and J H Scarpello
January 1971, Naika. Internal medicine,
Copied contents to your clipboard!